Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s Role In Artificial Intelligence/Machine Learning Development Is ‘Convener,’ Califf Says

Jan 19 2024

• By Derrick Gingery

Artificial intelligence — • Source: Shutterstock

Related Content

Artificial Intelligence: Industry Wants FDA To Boost Access To Databases, Clarify Use In Assessing Drug Efficacy

Sep 07 2023

AI In Drug Development: FDA Wants To Know How To Assure Data Integrity, Transparency, Reliability

May 11 2023

FDA’s CDER Is Fostering Use Of Artificial Intelligence In Drug Development

Mar 01 2023

The Long Learning Curve For Artificially Intelligent Drug Manufacturing Begins Now

Dec 29 2023

Artificial Intelligence Legislative Activity To Start In Fall; Sen. Schumer Lays Out Principles, Process

Jul 06 2023

EMA, US FDA Worry About AI’s Pitfalls And Promises

Jul 24 2023

How The EU’s Landmark AI Act Could Impact The Pharma Industry

Jan 02 2024

Additional Topics

United States International Artificial Intelligence Consumer Regulation Research & Development Digital Health FDA BioPharmaceutical

More from Digital Technologies

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window